Facing the Challenge of Drug-Induced Acute Interstitial Nephritis
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Acute interstitial nephritis (AIN) is one of the chief causes of acute kidney injury (AKI). AIN might be produced by drugs, infections, autoimmune diseases, or can be idiopathic. Among these etiologies, drug-induced AIN (DI-AIN) is the dominant one in many countries. Even when DI-AIN is suspected, identification of the putative drug is challenging. Summary: DI-AIN is an increasingly common cause of AKI. Diagnosis continues to pose a challenge for physicians due to nonspecific clinical symptoms, and the fact that it can be triggered by a wide variety of medications. Furthermore, the gold standard for the diagnosis is kidney biopsy. All these aspects render the diagnosis more difficult. The withdrawal of the causative drug of DI-AIN is the centerpiece of the treatment, and if early restoration of original kidney function is not obtained, several studies support the treatment with steroids especially when they are started quickly. Key Messages: Almost all drugs have the potential to produce drug-induced acute interstitial nephritis (DI-AIN); however, antibiotics, nonsteroidal anti-inflammatory agents, and proton pump inhibitors account for the majority of the reported cases. DI-AIN is produced by an idiosyncratic delayed type IV hypersensitivity reaction, but the precise pathophysiological mechanism remains to be elucidated. DI-AIN symptoms are nonspecific, and most of the patients will present mild symptoms including malaise, nausea, and vomiting. The classical triad, associating fever, rash, and eosinophilia, is seldom present. Nonoliguric acute kidney injury is the main renal manifestation of DI-AIN. Tubular nonnephrotic range proteinuria is usually present. Diagnosis of DI-AIN relies on maintaining a high index of suspicion in those patients at greater risk, but kidney biopsy is required to confirm diagnosis. Histologically, AIN is characterized by the presence of an extensive interstitial infiltrate, mainly composed of lymphocytes and monocytes, but eosinophils, plasma cells, histiocytes, and polymorphonuclear cells can also be found. The withdrawal of the presumed causative drug of DI-AIN is the mainstay of the treatment. When there is no evidence of kidney function recovery after an interval of 5–7 days since interrupting the treatment with the suspected drug, several studies support the treatment with steroids, especially when they are promptly started. Early corticosteroids would decrease the inflammatory infiltrates of the kidney interstitium, thus preventing the risk of subsequent fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
Drug-induced acute interstitial nephritis
Rossert, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002804.x · Cited by 488
González, E., Gutiérrez, E., Galeano, C., Chevia, C., de Sequera, P., Bernis, C., Parra, E. G., Delgado, R., Sanz, M., Ortiz, M., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002776 · Cited by 466
Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study
Cortazar, F. B., Kibbelaar, Z. A., Glezerman, I. G., Abudayyeh, A., Mamlouk, O., Motwani, S. S., Murakami, N., Herrmann, S. M., Manohar, S., Shirali, A. C., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019070676 · Cited by 407
Drug-induced acute interstitial nephritis
Perazella, M. A., & Markowitz, G. S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.71 · Cited by 378
Acute interstitial nephritis: clinical features and response to corticosteroid therapy
Clarkson, M. R. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh485 · Cited by 343
Biopsy-proven acute interstitial nephritis, 1993-2011: a case series
Muriithi, A. K., Leung, N., Valeri, A. M., Cornell, L. D., Sethi, S., Fidler, M. E., & Nasr, S. H. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.04.027 · Cited by 337
Antitubular Basement-Membrane Antibodies in Methicillin-Associated Interstitial Nephritis
Border, W. A., Lehman, D. H., Egan, J. D., Sass, H. J., Glode, J. E., & Wilson, C. B. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408222910803 · Cited by 246
Acute interstitial nephritis â a reappraisal and update
Raghavan, R., & Eknoyan, G. (2014) · Clinical Nephrology · doi:10.5414/cn10838 · Cited by 180
Councilman, W. T. (1898) · Journal of Experimental Medicine · doi:10.1084/jem.3.4-5.393 · Cited by 159
Acute Interstitial Nephritis: A Clinical and Morphological Study in 27 Patients
Buysen, J. G. M., Houthoff, H. J., Krediet, R. T., & Arisz, L. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.2.94 · Cited by 157
Involvement of Drug-Specific T Cells in Acute Drug-Induced Interstitial Nephritis
Spanou, Z., Keller, M., Britschgi, M., Yawalkar, N., Fehr, T., Neuweiler, J., Gugger, M., Mohaupt, M., & Pichler, W. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050418 · Cited by 151
Praga, M., Sevillano, A., Auñón, P., & González, E. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu326 · Cited by 147
Fernandez-Juarez, G., Perez, J. V., Caravaca-Fontán, F., Quintana, L., Shabaka, A., Rodriguez, E., Gadola, L., de Lorenzo, A., Cobo, M. A., Oliet, A., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01390118 · Cited by 133
Mechanisms of Drug-Induced Interstitial Nephritis
Raghavan, R., & Shawar, S. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.004 · Cited by 117
Review: Acute tubulointerstitial nephritis
Toto, R. D. (1990) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199006000-00007 · Cited by 94
Urinary Sediment Findings in Acute Interstitial Nephritis
Fogazzi, G. B., Ferrari, B., Garigali, G., Simonini, P., & Consonni, D. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.05.002 · Cited by 71
Diagnosing acute interstitial nephritis: considerations for clinicians
Nussbaum, E. Z., & Perazella, M. A. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz080 · Cited by 29
The challenges of acute interstitial nephritis: time to standardize
Moledina, D. G., & Perazella, M. A. (2021) · Kidney360 · doi:10.34067/kid.0001742021 · Cited by 25
New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition
Martinez Valenzuela, L., Draibe, J., Fulladosa, X., & Torras, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134690 · Cited by 19
Jia, Y., Su, T., Gu, Y., Li, C., Zhou, X., Su, J., Sun, P., Tang, J., Yang, L., Liu, G., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800237 · Cited by 18
Management of Drug-Associated Acute Interstitial Nephritis
Barreto, E. F., & Rule, A. D. (2020) · Kidney360 · doi:10.34067/kid.0000042019 · Cited by 16
Cited by
Miao, J., & Herrmann, S. M. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad109 · Cited by 31
“The resultant metabolites are presented to dendritic cells that are located in kidney interstitial tissue, leading to subsequent T-cell-mediated immune response [62].”
BackgroundInfluentialMiao, J., Thongprayoon, C., Krisanapan, P., Buglioni, A., Craici, I. M., & Cheungpasitporn, W. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.026 · Cited by 18
Clozapine-Induced Acute Interstitial Nephritis
Ragg, J., Innes, S., Bannon, F., & Hope, J. (2026) · Journal of clinical psychopharmacology · doi:10.1097/jcp.0000000000002192 · Cited by 2
Metadata
- Authors
- Sanchez-Alamo, B., Cases-Corona, C., & Fernandez-Juarez, G.
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 2022-07-13
- Volume
- 147
- Issue
- 2
- Pages
- 78-90
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W4285394439
- Cited by
- 71
- References
- 22
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.